Literature DB >> 12929150

Reliability of data from next-of-kin: results from a case-control study of occupational and lifestyle risk factors for cancer.

Linda Kaerlev1, Elsebeth Lynge, Svend Sabroe, Jorn Olsen.   

Abstract

BACKGROUND: Use of surrogate responders often needs to be considered in case-control studies with a high case fatality.
METHODS: Agreement between 98 colon cancer patients and their closest relative was expressed as a percentage of the exact agreement and by Kappa coefficients and intra-class correlation coefficients.
RESULTS: The percentage of "don't know" answers was higher for surrogates than for index cases and the highest percentage was seen for questions on early events like childhood diseases. Agreement was best for responses to dichotomous questions on smoking and for prevalent or chronic diseases like diabetes or psoriasis, and lower (54-64%) when a quantitative response of, e.g., smoking was requested. The next-of-kin reported fewer job periods than the study person, 4.5 and 2.8, respectively, and there was a higher agreement for the latest job held than for the longest held job. We found an overall agreement between 91% and 100% for responses to ever having worked in a specific type of industry or occupation.
CONCLUSIONS: Use of next-of-kin data will often be a better alternative than excluding severely ill or deceased cases, if the exposure under study correlates with disease progression. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12929150     DOI: 10.1002/ajim.10266

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  2 in total

1.  Accuracy of Smoking Status Reporting: Proxy Information in a Rapidly Fatal Cancer Setting.

Authors:  Maria A Stevens; Kari G Rabe; Ben Boursi; Aarti Kolluri; Dhruv P Singh; William R Bamlet; Gloria M Petersen
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-12-10

2.  Colon cancer controls versus population controls in case-control studies of occupational risk factors.

Authors:  Linda Kaerlev; Elsebeth Lynge; Svend Sabroe; Jorn Olsen
Journal:  BMC Cancer       Date:  2004-04-22       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.